期刊文献+

他克莫司和雷帕酶素在肾移植术后血肌酐升高患者中的疗效观察 被引量:1

Clinical observation of FK506 and RPM in recipients following renal transplantation with increasing serum creatinine
暂未订购
导出
摘要 目的探讨肾移植术后血肌酐升高患者使用他克莫司(FK506)和雷帕霉素(RPM)的有效性。方法49例肾移植受者血肌酐升高至310~650μmol/L采用FK506、RPM、泼尼松三联用药。结果治疗8周后24例肾功能恢复正常,17例血肌酐明显下降,8例无效。结论FK506和RPM用于肾移植术后血肌酐升高早期患者是有效的。 [ Objective ] To study the efficacy of FKS06 and RPM to the patient following renal transplantation with increasing serum creatinine. [Method] 49 renal transplantation recipients with increasing serum creatinine between 310 to 650 μmol/L adopted triple immunosuppression therapy with FK506. RPM and Pred. [Result] After 8 weeks therapy, the renal function of 24 cases normalized, the serum creatinine of 17 cases descented obviously, 8 cases was ineffective. [Conclusion] FK506 and RPM have therapeautic effects on increasing serum creatinine following renal transplantation
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第15期2348-2349,2352,共3页 China Journal of Modern Medicine
关键词 他克莫司 雷帕霉素 肾移植 治疗结果 tacrolimus rapamycin renal transplantation therapeautic efficacy
  • 相关文献

参考文献8

  • 1夏穗生.临床肾移植[M].杭州:浙江科学技术出版社,2001:133.
  • 2AHUJASS,SHRIVASTAVS,DANIELPOURD,et al.Regulation of transforming grouth factor-beta Ⅰ and its receptor by cyclosporine in human T Iymphocytes[J].Transplantation,1995,6(7):718-723.
  • 3BORDER WA.Transforming growth factor-beta and the pathogenesis of glomerutar disease[J].Curr Opin Nephrol Hypertens,1994,3(1):54-58.
  • 4WANG T,DONAHOE PK,ZERVOS AS.Specific interaction of type receptors of the TGFbeta family with the imunophilin FKBP12[J].science,1994,265:674-676.
  • 5HUTCHINSON IV.The mode of action of prograf (lacrolimus) and its significance for Long-term graft survival[J].New Horiz kid Transplant,1997,1(1):22-26.
  • 6方针强,张艮甫,黄赤兵,范明齐.Simulect和OKT3诱导治疗应用于肾移植临床的疗效比较(英文)[J].中国现代医学杂志,2004,14(22):9-11. 被引量:5
  • 7魏淑贞,张德奎,姜山,藏运金.肝移植术后服用他克莫司致神经毒性反应的观察[J].中国现代医学杂志,2004,14(6):90-91. 被引量:13
  • 8MUTHUKKUMAR S,RAMESH TM,BONDADA S.Rapamycin,a potent immunosuppressive drugs,causes programmed cell death in B lymphoma cells[J].Transplantation,1995,60:264-270.Chin J Organ Transplant,2002,22:160-161.

二级参考文献7

  • 1Matas AJ, Gillingham KJ, Payne WD, Najarian JS. Impact of an acute rejection episode on long-term renal allograft survival (t1/2)[J].Transplantation, 1994, 57: 857-859.
  • 2Ortho Multicentre Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for the rejection of cadaveric renal transplants[J]. N Engl J Med 1985, 313(6): 337-342.
  • 3Nashan B, Moore R, Amlot P, et al. Randomised trial of basiliximab versus placebo for control of acute cellur rejection in renal allograft recipients[J]. Lancet, 1997, 350: 1193-1198.
  • 4Kahan BD, Rajagopalan PR, Michael Hall. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody[J]. Transplantation, 1999, 67: 276-284.
  • 5Mitchell LH, Amer R. The use of basiliximab in solid organ transplantation[J]. Drug Evaluation, 2002, 3(11): 1657-1663.
  • 6朱有华,闵志廉,王立明,齐隽,王亚伟,周梅生,郑军华,任吉忠,徐丹枫,姚亚成,董震.普乐可复在肾移植中的临床应用[J].中华器官移植杂志,2000,21(2):119-121. 被引量:21
  • 7吴问汉,万远廉,杨尹默,詹江华,赵建勋,黄延庭.肝移植术后早期并发症[J].中国现代医学杂志,2001,11(8):1-3. 被引量:10

共引文献16

同被引文献12

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部